Blocking anti-inflammatory mediators like exposed annexin A1 that arise due to treatment induced tumor cell apoptosis could tip the balance from an anti- to a pro-inflammatory tumor environment and, thus, facilitate tumor antigen recognition and tumor rejection. Here, ANXA1 is linked to neoplasm.